Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, will be participating in the following virtual investor conferences.
- March 9 – 10, 2021 – Dr. James A. Hayward, president and CEO, will present a company overview at the H.C. Wainwright Global Life Sciences Virtual Conference. Dr. Hayward and Beth Jantzen, chief financial officer, will also hold virtual investor meetings. Dr. Hayward’s pre-recorded presentation will be available for viewing beginning March 9 at 7:00 A.M. (ET). The presentation will also be available on Applied DNA’s website ( link );
- March 15 – 17, 2021 – Dr. Hayward will participate on a virtual panel at Roth Capital Markets’ 33 rd Annual Conference titled ‘Therapeutics Against SARS-CoV-2 – Viral variants Will Not Fade Away’. The panel is scheduled for March 15, 2021 at 12:00pm ET and will be available to all Conference attendees, as well as on Applied DNA’s website ( link ). Management will also hold virtual investor meetings;
- March 17 – 19, 2021 – Dr. Hayward will present at the Inaugural Emerging Growth Virtual Conference presented by M Vest LLC and Maxim Group LLC. The presentation will be available to all registered participants of the conference ( link ) on March 17 th - 19 th and will be posted on Applied DNA’s website ( link ) after March 19.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping, and pre-clinical nucleic acid-based therapeutic drug candidates.
Visit adnas.com for more information. Follow us on Twitter and LinkedIn . Join our mailing list .
The Company’s common stock is listed on NASDAQ under ticker symbol ‘APDN’, and its publicly traded warrants are listed on OTC under ticker symbol ‘APPDW’.
Applied DNA is a member of the Russell Microcap® Index.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210308005635/en/
Investor contact: Sanjay M. Hurry, Applied DNA Sciences, 917-733-5573, sanjay.hurry@adnas.com
Web: www.adnas.com
Twitter: @APDN